These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35353163)

  • 1. Impact of Topical Interventions on the Vaginal Microbiota and Metabolome in Postmenopausal Women: A Secondary Analysis of a Randomized Clinical Trial.
    Srinivasan S; Hua X; Wu MC; Proll S; Valint DJ; Reed SD; Guthrie KA; LaCroix AZ; Larson JC; Pepin R; Bhasin S; Raftery D; Fredricks DN; Mitchell CM
    JAMA Netw Open; 2022 Mar; 5(3):e225032. PubMed ID: 35353163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between postmenopausal vulvovaginal discomfort, vaginal microbiota, and mucosal inflammation.
    Mitchell CM; Ma N; Mitchell AJ; Wu MC; Valint DJ; Proll S; Reed SD; Guthrie KA; Lacroix AZ; Larson JC; Pepin R; Raftery D; Fredricks DN; Srinivasan S
    Am J Obstet Gynecol; 2021 Aug; 225(2):159.e1-159.e15. PubMed ID: 33675793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms: A Randomized Clinical Trial.
    Mitchell CM; Reed SD; Diem S; Larson JC; Newton KM; Ensrud KE; LaCroix AZ; Caan B; Guthrie KA
    JAMA Intern Med; 2018 May; 178(5):681-690. PubMed ID: 29554173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-centered change in the day-to-day impact of postmenopausal vaginal symptoms: results from a multicenter randomized trial.
    Gibson CJ; Huang AJ; Larson JC; Mitchell C; Diem S; LaCroix A; Newton KM; Reed SD; Guthrie KA
    Am J Obstet Gynecol; 2020 Jul; 223(1):99.e1-99.e9. PubMed ID: 31954158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual frequency and pain in a randomized clinical trial of vaginal estradiol tablets, moisturizer, and placebo in postmenopausal women.
    Mitchell CM; Guthrie KA; Larson J; Diem S; LaCroix AZ; Caan B; Shifren JL; Woods NF; Heiman JR; Lindau ST; Reed SD
    Menopause; 2019 Aug; 26(8):816-822. PubMed ID: 30994576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Vaginal Estradiol Tablet With Serum Estrogen Levels in Women Who Are Postmenopausal: Secondary Analysis of a Randomized Clinical Trial.
    Mitchell CM; Larson JC; Crandall CJ; Bhasin S; LaCroix AZ; Ensrud KE; Guthrie KA; Reed SD
    JAMA Netw Open; 2022 Nov; 5(11):e2241743. PubMed ID: 36374501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial.
    Diem SJ; Guthrie KA; Mitchell CM; Reed SD; Larson JC; Ensrud KE; LaCroix AZ
    Menopause; 2018 Oct; 25(10):1086-1093. PubMed ID: 29738424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom.
    Kroll R; Archer DF; Lin Y; Sniukiene V; Liu JH
    Menopause; 2018 Feb; 25(2):133-138. PubMed ID: 28926514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between vaginal microbiota and vaginal inflammatory immune markers in postmenopausal women.
    Byrne EH; Song H; Srinivasan S; Fredricks DN; Reed SD; Guthrie KA; Wu M; Mitchell CM
    Menopause; 2024 Jul; 31(7):575-581. PubMed ID: 38713891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
    Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
    J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between improvement in genitourinary symptoms of menopause and changes in the vaginal ecosystem.
    Mitchell CM; Srinivasan S; Plantinga A; Wu MC; Reed SD; Guthrie KA; LaCroix AZ; Fiedler T; Munch M; Liu C; Hoffman NG; Blair IA; Newton K; Freeman EW; Joffe H; Cohen L; Fredricks DN
    Menopause; 2018 May; 25(5):500-507. PubMed ID: 29206774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Fractional Carbon Dioxide vs Sham Laser on Sexual Function in Survivors of Breast Cancer Receiving Aromatase Inhibitors for Genitourinary Syndrome of Menopause: The LIGHT Randomized Clinical Trial.
    Mension E; Alonso I; Anglès-Acedo S; Ros C; Otero J; Villarino Á; Farré R; Saco A; Vega N; Castrejón N; Ordi J; Rakislova N; Tortajada M; Matas I; Gómez S; Ribera L; Castelo-Branco C
    JAMA Netw Open; 2023 Feb; 6(2):e2255697. PubMed ID: 36763359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TX-004HR Improves Sexual Function as Measured by the Female Sexual Function Index in Postmenopausal Women With Vulvar and Vaginal Atrophy: The REJOICE Trial.
    Kingsberg SA; Derogatis L; Simon JA; Constantine GD; Graham S; Bernick B; Gasper G; Mirkin S
    J Sex Med; 2016 Dec; 13(12):1930-1937. PubMed ID: 27692842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms: A Randomized Clinical Trial.
    Li FG; Maheux-Lacroix S; Deans R; Nesbitt-Hawes E; Budden A; Nguyen K; Lim CY; Song S; McCormack L; Lyons SD; Segelov E; Abbott JA
    JAMA; 2021 Oct; 326(14):1381-1389. PubMed ID: 34636862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of Pueraria mirifica gel and of placebo gel on the vaginal microenvironment of postmenopausal women with Genitourinary Syndrome of Menopause (GSM).
    Sritonchai C; Manonai J; Sophonsritsuk A; Cherdshewasart W
    Maturitas; 2020 Oct; 140():49-54. PubMed ID: 32972635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local oestrogen for vaginal atrophy in postmenopausal women.
    Lethaby A; Ayeleke RO; Roberts H
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001500. PubMed ID: 27577677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consistency of Effect with a Low-Dose, Estradiol Vaginal Capsule (TX-004HR): Evaluating Improvement in Vaginal Physiology and Moderate-to-Severe Dyspareunia in Subgroups of Postmenopausal Women.
    Constantine GD; Bouchard C; Pickar JH; Archer DF; Graham S; Bernick B; Mirkin S
    J Womens Health (Larchmt); 2017 Jun; 26(6):616-623. PubMed ID: 28355090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Lin SQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol.
    Pickar JH; Amadio JM; Hill JM; Bernick BA; Mirkin S
    Menopause; 2016 May; 23(5):506-10. PubMed ID: 26836245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy.
    Constantine GD; Simon JA; Pickar JH; Archer DF; Kushner H; Bernick B; Gasper G; Graham S; Mirkin S;
    Menopause; 2017 Apr; 24(4):409-416. PubMed ID: 27922936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.